Adamas Biotech Srl focuses on developing innovative nutraceuticals that harness the beneficial properties of green tea extracts (GTEs), particularly from the Camellia sinensis plant. Their proprietary extract, Theaphenon E®, boasts a high concentration of catechins and epigallocatechin gallate, which are known for their antioxidant, anti-inflammatory, and anti-angiogenic effects. The company emphasizes a rigorous approach to product development, adhering to pharmaceutical-grade standard operating procedures (SOPs) to ensure the purity and efficacy of their formulations. Their product pipeline addresses various health concerns, including lower urinary tract symptoms, gastrointestinal health, dermatological issues, and sports medicine, all supported by clinical research.

The company's commitment to combining scientific rigor with nature-based solutions is evident in their ongoing research and product development. For instance, Theakine® is being developed to improve gastrointestinal health and support the microbiome, while another formulation targets skin recovery and anti-aging benefits. Additionally, Adamas Biotech is exploring applications for athletes, aiming to enhance performance and endurance through their nutraceuticals. Their mission is to advance health and well-being through sustainable, evidence-based solutions, pushing the boundaries of nutraceutical sciences to improve quality of life globally.

Italy

Adamas Biotech is a clinical stage company pioneering the development of nutraceutical-based prophylactic and therapeutic solutions for a range of clinical and wellness indications. The company is specialized in the development of bioactive molecules derived from botanicals, in particular, green tea catechins. 
Its initial pipeline is based on 100% natural formulations of green tea purified compounds, which are under development for use in cancer prevention, anti-aging, wound care and sports medicine.

Adamas Biotech Srl

Company Details